Skip to Main content Skip to Navigation
Journal articles

Applicability of the REDUCE‐IT trial to the FAST‐MI registry. Are the results of randomized trials relevant in routine clinical practice?

Jean Ferrières Vincent Bataille Etienne Puymirat François Schiele Tabassome Simon 1 Nicolas Danchin
1 PASS-CRB-APHP-SU - Centre de Ressources Biologiques APHP-SU
PASS - Unité Mixte de Service Production et Analyse de données en Sciences de la vie et en Santé
Abstract : Background: The reduction of cardiovascular events with icosapent ethyl-intervention trial (REDUCE-IT) trial revealed robust atherosclerotic cardiovascular risk reduction with a strategy comprising high-dose omega-3 icosapent ethyl vs placebo in statin-treated patients with elevated triglycerides and controlled low-density lipoprotein cholesterol (LDL-C).
Document type :
Journal articles
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-03028635
Contributor : Nadège Brunel <>
Submitted on : Friday, November 27, 2020 - 4:30:10 PM
Last modification on : Wednesday, March 3, 2021 - 8:50:02 AM
Long-term archiving on: : Sunday, February 28, 2021 - 8:16:08 PM

File

CLC-43-1260.pdf
Publisher files allowed on an open archive

Identifiers

Citation

Jean Ferrières, Vincent Bataille, Etienne Puymirat, François Schiele, Tabassome Simon, et al.. Applicability of the REDUCE‐IT trial to the FAST‐MI registry. Are the results of randomized trials relevant in routine clinical practice?. Clinical Cardiology, Wiley, 2020, 43, pp.1260 - 1265. ⟨10.1002/clc.23437⟩. ⟨hal-03028635⟩

Share

Metrics